Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000468207 | SCV000551298 | benign | Hereditary nonpolyposis colorectal neoplasms | 2024-12-25 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000564743 | SCV000662371 | uncertain significance | Hereditary cancer-predisposing syndrome | 2024-04-28 | criteria provided, single submitter | clinical testing | The p.R26G variant (also known as c.76A>G), located in coding exon 1 of the MSH6 gene, results from an A to G substitution at nucleotide position 76. The arginine at codon 26 is replaced by glycine, an amino acid with dissimilar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Baylor Genetics | RCV004568058 | SCV005054911 | uncertain significance | Endometrial carcinoma | 2024-02-19 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV004806329 | SCV005429185 | likely benign | Lynch syndrome | 2024-08-13 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV005056025 | SCV005726226 | uncertain significance | not specified | 2024-11-16 | criteria provided, single submitter | clinical testing |